"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT02205307","A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection","PILLAR III","Terminated","Has Results","Rectal Cancer|Rectosigmoid Cancer","Device: PINPOINT|Device: SPY Elite","Anastomotic Leak Rate|Rate of SPY Visualization and Tissue Perfusion|Incidence of Post-Operative Abscess Requiring Surgical Management","Novadaq Technologies ULC, now a part of Stryker","All","18 Years and older   (Adult, Older Adult)","Not Applicable","347","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","PP PLR 03","January 2015","May 2017","May 2017","July 31, 2014","June 24, 2020","June 24, 2020","John Muir Medical Center, Concord Campus, Concord, California, United States|Kaiser Permanente, Los Angeles, California, United States|University of California, Irvine, Orange, California, United States|University of California, San Francisco, San Francisco, California, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|University of South Florida, Tampa, Florida, United States|Cleveland Clinic Florida, Weston, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|Indiana University, Indianapolis, Indiana, United States|Ochsner Clinic, New Orleans, Louisiana, United States|Johns Hopkins, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Barnes Jewish Medical Center, Saint Louis, Missouri, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States|Mount Sinai Beth Israel, New York, New York, United States|Mount Sinai Medical Center, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|The Christ Hospital, Cincinnati, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Baylor University Medical Center, Dallas, Texas, United States|Methodist Hospital, Houston, Texas, United States","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/07/NCT02205307/Prot_000.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/07/NCT02205307/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT02205307"
2,"NCT01969448","Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction","NASSM","Completed","Has Results","Ductal Carcinoma in Situ - Category|Breast Cancer|Prophylactic Mastectomy","Procedure: Inframammary Fold Incision or Lateral Radial Incision|Procedure: Lateral Radial Incision|Procedure: Inframammary Fold Incision|Device: Laser-assisted fluorescence angiography|Drug: Indocyanine Green","Percentage of Original Preoperative Blood Supply (Perfusion) Post Nipple Sparing Mastectomy|Percentage of Original Preoperative Blood Supply (Perfusion) Post Reconstruction|Breast Q Score|Number of Participants With Tissue Expander|Mean Operative Times for Mastectomy|Breast Weight","Washington University School of Medicine|LifeCell","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","79","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","201302004","March 28, 2013","April 27, 2016","April 17, 2017","October 25, 2013","April 18, 2018","April 18, 2018","Washington University School of Medicine, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT01969448"
3,"NCT01771666","Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer",,"Completed","Has Results","Breast Cancer","Device: SPY Elite Imaging|Drug: Indocyanine Green|Drug: Isosulfan blue|Drug: 99technetium-sulfur colloid radiolabel","Agreement of Labeling Between Isosulfan Blue (IS-BLUE) and Indocyanine Green (IC-GREEN)|Detection of Indocyanine Green (IC-GREEN); Isosulfan Blue (IS-BLUE); and 99technetium-sulfur Colloid Radiolabel in Resected Sentinel Nodes","Stanford University","Female","18 Years to 90 Years   (Adult, Older Adult)","Phase 2","23","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","IRB-21030|SU-06122012-10130|BRS0022","July 2012","March 17, 2015","March 17, 2015","January 18, 2013","December 11, 2017","December 11, 2017","Stanford University, School of Medicine, Stanford, California, United States",,"https://ClinicalTrials.gov/show/NCT01771666"
4,"NCT02057393","Infrared Lymphangiography as a Method of Sentinel Node Identification","SPY-SN","Completed","Has Results","Melanoma|Sentinel Node","Drug: Indocyanine green|Drug: Technetium99|Drug: Methylene blue","Equivalence of ICG and Real Time Lymphangiography to technetium99 and Blue Dye in Localizing Sentinel Nodes","Milton S. Hershey Medical Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","89","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","247374","June 2014","January 2016","February 2016","February 7, 2014","June 6, 2017","July 6, 2017","Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT02057393"
